510(k) K251281— Nova Max Creat eGFR Monitoring System

Substantially Equivalent

Nova Biomedical Corporation

Clearance details

Applicant
Nova Biomedical Corporation
Product code
Code SHB
Advisory panel
Clinical Chemistry
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Walham, MA, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.